Follow
John Floberg
John Floberg
University of Wisconsin, Department of Human Oncology
Verified email at humonc.wisc.edu
Title
Cited by
Cited by
Year
Dynamic PET denoising with HYPR processing
BT Christian, NT Vandehey, JM Floberg, CA Mistretta
Journal of Nuclear Medicine 51 (7), 1147-1154, 2010
1402010
Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy
JP Weichert, PA Clark, IK Kandela, AM Vaccaro, W Clarke, MA Longino, ...
Science translational medicine 6 (240), 240ra75-240ra75, 2014
1302014
Radioresistant cervical cancers are sensitive to inhibition of glycolysis and redox metabolism
R Rashmi, X Huang, JM Floberg, AE Elhammali, ML McCormick, GJ Patti, ...
Cancer research 78 (6), 1392-1403, 2018
772018
Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the N ational C ancer D atabase
BW Fischer‐Valuck, I Chen, AJ Srivastava, JM Floberg, YJ Rao, AA King, ...
Cancer 123 (4), 682-687, 2017
652017
The sensitivity and specificity of F-DOPA PET in a movement disorder clinic
N Ibrahim, J Kusmirek, AF Struck, JM Floberg, SB Perlman, C Gallagher, ...
American Journal of Nuclear Medicine and Molecular Imaging 6 (1), 102, 2016
622016
Surgical decision making in temporal lobe epilepsy: A comparison of [18F] FDG-PET, MRI, and EEG
AF Struck, LT Hall, JM Floberg, SB Perlman, DA Dulli
Epilepsy & Behavior 22 (2), 293-297, 2011
482011
Improved kinetic analysis of dynamic PET data with optimized HYPR‐LR
JM Floberg, CA Mistretta, JP Weichert, LT Hall, JE Holden, BT Christian
Medical physics 39 (6Part1), 3319-3331, 2012
452012
Manipulation of glucose and hydroperoxide metabolism to improve radiation response
JM Floberg, JK Schwarz
Seminars in radiation oncology 29 (1), 33-41, 2019
282019
Longitudinal molecular profiling of circulating tumor cells in metastatic renal cell carcinoma
M Bootsma, RR McKay, H Emamekhoo, RM Bade, JL Schehr, ...
Journal of Clinical Oncology 40 (31), 3633, 2022
172022
Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer
JM Floberg, J Zhang, N Muhammad, TA DeWees, M Inkman, K Chen, ...
Clinical Cancer Research 27 (15), 4245-4255, 2021
152021
18F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison
AF Struck, LT Hall, JE Kusmirek, CL Gallagher, JM Floberg, CJ Jaskowiak, ...
American Journal of Nuclear Medicine and Molecular Imaging 2 (4), 475, 2012
142012
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
JM Floberg, TA DeWees, RI Chin, AA Garsa, F Dehdashti, B Nussenbaum, ...
Head & Neck 40 (10), 2280-2287, 2018
132018
Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT
JJ Grudzinski, JM Floberg, SR Mudd, JJ Jeffery, ET Peterson, A Nomura, ...
Physics in Medicine & Biology 57 (6), 1641, 2012
132012
Alteration of cellular reduction potential will change 64Cu-ATSM signal with or without hypoxia
JM Floberg, L Wang, N Bandara, R Rashmi, C Mpoy, JR Garbow, ...
Journal of Nuclear Medicine 61 (3), 427-432, 2020
112020
Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer
JM Floberg, KJ Fowler, D Fuser, TA DeWees, F Dehdashti, BA Siegel, ...
EJNMMI research 8, 1-10, 2018
102018
Nonlinear spatio-temporal filtering of dynamic PET data using a four-dimensional Gaussian filter and expectation-maximization deconvolution
JM Floberg, JE Holden
Physics in Medicine & Biology 58 (4), 1151, 2013
82013
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
SG Zhao, JM Sperger, JL Schehr, RR McKay, H Emamekhoo, A Singh, ...
The Journal of Clinical Investigation 132 (21), 2022
72022
Pre-treatment [F-18] FDG-PET SUVmax as a prognostic and radiogenomic marker in cervical cancer
JM Floberg, J Zhang, TA DeWees, S Markovina, PW Grigsby, JK Schwarz
International Journal of Radiation Oncology, Biology, Physics 102 (3), S82-S83, 2018
62018
Combining stereotactic body radiotherapy and microwave ablation appears safe and feasible for renal cell carcinoma in an early series
GC Blitzer, A Wojcieszynski, EJ Abel, S Best, FT Lee Jr, JL Hinshaw, ...
Clinical Genitourinary Cancer 19 (5), e313-e318, 2021
52021
Altering cellular reducing potential changes 64Cu-ATSM signal with or without hypoxia
JM Floberg, L Wang, N Bandara, R Rashmi, C Mpoy, JR Garbow, ...
Journal of Nuclear Medicine, 2019
42019
The system can't perform the operation now. Try again later.
Articles 1–20